1 |
CE-VST01-JC
| [1] CE-VST01-JC CE-VST01-JC | - | - | - | [1] 25 25 |
2 |
Cidofovir
| [1] Cidofovir Cidofovir | [1] D00273
D00273
| - | - | [1] 25 25 |
3 |
Cytarabine
| [1] Cytarabine Cytarabine | [1] D00168
D00168
| - | - | [7] 11 11, 13, 14, 25, 49, 60, 65 |
4 |
Didanosine
| [1] Didanosine Didanosine | [1] D00296
D00296
| - | - | [2] 25 25, 265 |
5 |
Efineptakin alfa
| [1] NT-I7 NT-I7 | [1] D11957
D11957
| - | - | [1] 25 25 |
6 |
Emtricitabine
| [2] Emtricitabine Emtricitabine; TRUVADA | [1] D01199
D01199
| - | - | [4] 25 25, 93, 265, 325 |
7 |
Enfuvirtide
| [1] Enfuvirtide Enfuvirtide | [1] D02499
D02499
| - | - | [2] 25 25, 265 |
8 |
Filgrastim
| [7] Filgrastim Filgrastim; Filgrastim Hexal; G-CSF; Granulocyte Colony Stimulating Factor; Neupogen; TEVAGRASTIM; Zarzio | [1] D03235
D03235
| [1] CSF3R CSF3R 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [35] 2 2, 6, 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
9 |
Interferon alfa
| [1] Interferon alfa Interferon alfa | [1] D03305
D03305
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [6] 13 13, 25, 26, 28, 56, 96 |
10 |
Interferon alfa-2b
| [2] Interferon alfa-2b Interferon alfa-2b; Interferon alpha-2B | [1] D02745
D02745
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [2] 25 25, 34 |
11 |
Interleukin-7
| [2] Interleukin-7 Interleukin-7; Recombinant human interleukin-7 | - | - | - | [1] 25 25 |
12 |
Mefloquine
| [2] Lariam Lariam; Mefloquine | [1] D04895
D04895
| - | - | [2] 25 25, 46 |
13 |
Methylprednisolone
| [4] Medrol Medrol; Methylprednisolon; Methylprednisolone; Methylprednisolone acetate | [1] D00407
D00407
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [46] 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 |
14 |
Natalizumab
| [2] NATALIZUMAB NATALIZUMAB; TYSABRI | [1] D06886
D06886
| [1] ITGA4 ITGA4 💬 | [14] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [6] 13 13, 15, 25, 46, 63, 96 |
15 |
Pembrolizumab
| [1] Pembrolizumab Pembrolizumab | [1] D10574
D10574
| [1] PDCD1 PDCD1 💬 | [3] Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | [2] 25 25, 285 |
16 |
Prednisolone
| [3] Prednisolona Prednisolona; Prednisolone; Prednisolonum | [1] D00472
D00472
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [42] 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
17 |
Probenecid
| [1] Probenecid Probenecid | [1] D00475
D00475
| - | - | [1] 25 25 |
18 |
Tenofovir
| [1] Tenofovir Tenofovir | [1] D06074
D06074
| - | - | [6] 2 2, 13, 25, 93, 265, 325 |
19 |
Teriflunomide
| [2] AUBAGIO AUBAGIO; TERIFLUNOMIDE | [1] D10172
D10172
| [1] DHODH DHODH 💬 | [3] Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | [3] 13 13, 25, 26 |
20 |
Topotecan
| [1] Topotecan Topotecan | [1] D08618
D08618
| [1] TOP1 TOP1 💬 | - | [1] 25 25 |
21 |
Zalcitabine
| [1] Zalcitabine Zalcitabine | [1] D00412
D00412
| - | - | [1] 25 25 |
22 |
Zidovudine
| [3] COMBIVIR COMBIVIR; Retrovir; Zidovudine | [1] D00413
D00413
| - | - | [7] 25 25, 26, 94, 135, 265, 325, 331 |